Stuart J Connolly
Overview
Explore the profile of Stuart J Connolly including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
404
Citations
21646
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shoamanesh A, Field T, Coutts S, Sharma M, Gladstone D, Hart R, et al.
Lancet Neurol
. 2025 Jan;
24(2):140-151.
PMID: 39862882
Background: People with subclinical atrial fibrillation are at increased risk of stroke, albeit to a lesser extent than those with clinical atrial fibrillation, leading to an ongoing debate regarding the...
2.
Benz A, Alings M, Bosch J, Avezum A, Bhatt D, Healey J, et al.
Heart Rhythm
. 2025 Jan;
PMID: 39826637
Background: The Cardiovascular Outcomes for People Using Anticoagulation Strategies (COMPASS) trial enrolled patients with vascular disease but excluded patients requiring oral anticoagulation. Objective: We aimed to explore the clinical significance...
3.
Whitlock R, McCarthy P, Gerdisch M, Ramlawi B, Alexander J, Sultan I, et al.
Am Heart J
. 2024 Oct;
284:94-102.
PMID: 39395566
Introduction: Left atrial appendage exclusion (LAAE) has been shown in randomized trials to reduce ischemic stroke risk in patients undergoing cardiac surgery with known atrial fibrillation (AF). Many patients undergoing...
4.
Benz A, Meinel T, Salerno A, Beyeler M, Strambo D, Kaesmacher J, et al.
Ann Neurol
. 2024 Sep;
96(6):1115-1123.
PMID: 39344685
Objectives: To determine the prevalence and distribution of intracranial vessel occlusion identified on computed tomography (CT) or magnet resonance (MR) angiography and to explore its association with functional outcome in...
5.
McIntyre W, Benz A, Healey J, Connolly S, Yang M, Lee S, et al.
Circulation
. 2024 Sep;
150(22):1747-1755.
PMID: 39229707
Background: In the ARTESiA trial (Apixaban for the Reduction of Thromboembolism in Patients With Device-Detected Subclinical Atrial Fibrillation), apixaban, compared with aspirin, reduced stroke or systemic embolism in patients with...
6.
Lopes R, Granger C, Wojdyla D, McIntyre W, Alings M, Mani T, et al.
J Am Coll Cardiol
. 2024 Jul;
84(4):354-364.
PMID: 39019530
Background: ARTESiA (Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation) demonstrated that apixaban, compared with aspirin, significantly reduced stroke and systemic embolism (SE) but increased...
7.
Results of the COMPASS Trial Analyzed Using Win Ratio Compared With Conventional Analytic Approaches
Eikelboom J, Yi Q, McIntyre W, Bosch J, Whitlock R, Connolly S, et al.
Can J Cardiol
. 2024 Jul;
40(11):2171-2179.
PMID: 39002945
Background: Win ratio (WR) is a newer analytic approach for trials with composite end points that accounts for the relative importance of individual components. Our objective was to compare the...
8.
Johnson L, Mente A, Joseph P, Conen D, Benz A, McIntyre W, et al.
JAMA Netw Open
. 2024 Jul;
7(7):e2421589.
PMID: 38990569
Importance: Numerous prospective cohort studies have reported a J-shaped association of urinary sodium excretion with cardiovascular events and mortality. Objective: To study the association between sodium intake and incident atrial...
9.
Johnson L, Jiang Y, Luu J, Van Gelder I, Atzema C, Conen D, et al.
Eur Heart J
. 2024 Jun;
45(26):2336-2340.
PMID: 38833334
No abstract available.
10.
Connolly S, Sharma M, Cohen A, Demchuk A, Czlonkowska A, Lindgren A, et al.
N Engl J Med
. 2024 May;
390(19):1745-1755.
PMID: 38749032
Background: Patients with acute intracerebral hemorrhage who are receiving factor Xa inhibitors have a risk of hematoma expansion. The effect of andexanet alfa, an agent that reverses the effects of...